2MM: AI Roundup: Food and Drug Administration reviews liver injury prediction tool, Joint Commission launches healthcare artificial intelligence certification, governance playbooks aim to standardize adoption, and pediatric hospitals bring generative tools to the frontline

Food and Drug Administration reviews artificial intelligence tool for liver injury prediction The Food and Drug Administration (FDA) is reviewing an artificial intelligence based drug development tool designed to predict drug induced liver injury, one of the more stubborn safety problems in clinical development. The agency’s Center for Drug Evaluation and Research accepted a letter […] The post…